Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUGT1 pseudogene 2 (SUGT1P2) is classified as a pseudogene, meaning it shares sequence similarity with the SUGT1 gene but does not encode a functional protein. Pseudogenes do not produce active products and are not involved in known cellular pathways or disease processes. SUGT1P2 is annotated in human genomic databases with several alternative names referencing its homology to SGT1, a cochaperone involved in kinetochore complex assembly, but SUGT1P2 itself is not expressed or implicated in biology or medicine as a drug target[3][5]. This entry is not considered a valid therapeutic target, and structured data associating it with function, disease, pharmacology, or biomarkers should be omitted.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SUGT1 pseudogene 2 (SUGT1P2).